JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes
Clinical trial NCT06901934 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06901934
- Sponsor
- Zeinab Yahia Zaki
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.